Venofer treatment often leads to a notable increase in hemoglobin levels, although the exact increase can vary. According to the reference provided, a significant portion of patients experienced a substantial rise in hemoglobin levels after Venofer treatment.
Specifically:
- At the end of treatment, 66% of patients in the Venofer group had an increase in Hb ≥2.0 g/dL compared to 47% in the oral iron group (p=0.07).
This data indicates that Venofer is associated with a meaningful improvement in hemoglobin levels for a majority of patients. While not all patients will see this level of increase, it does represent a significant proportion of the treated population.
